Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer-Reference-Cited by-同舟云学术

Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer

Published:2017-10-20 Issue:1 Volume:9 Page:51-58
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Fukuda Minoru¹²^ORCID,Okumura Manabu³,Iwakiri Tomomi³,Arimori Kazuhiko³,Honda Takuya¹⁴,Kobayashi Kazuma⁵,Senju Hiroaki²,Takemoto Shinnosuke²,Ikeda Takaya²,Yamaguchi Hiroyuki²,Nakatomi Katsumi²,Matsuo Nobuko⁶,Mukae Hiroshi²,Ashizawa Kazuto¹⁷

Affiliation:

1. Clinical Oncology Center, Nagasaki University Hospital; Nagasaki Japan

2. Department of Respiratory Medicine; Nagasaki University Graduate School of Biomedical Sciences; Nagasaki Japan

3. Department of Pharmacy, Faculty of Medicine; University of Miyazaki Hospital; Miyazaki Japan

4. Department of Gastroenterology and Hepatology; Nagasaki University Graduate School of Biomedical Sciences; Nagasaki Japan

5. Department of Surgery; Nagasaki University Graduate School of Biomedical Sciences; Nagasaki Japan

6. Department of Respiratory Medicine; Nagasaki Harbor Medical Center City Hospital; Nagasaki Japan

7. Department of Clinical Oncology; Unit of Translational Medicine, Nagasaki University Graduate School of Biomedical Sciences; Nagasaki Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1759-7714.12535/fullpdf

Reference28 articles.

1. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I;Hsing;J Biol Chem,1985

2. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer;Noda;N Engl J Med,2002

3. Systemic therapy for colorectal cancer;Meyerhardt;N Engl J Med,2005

4. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: A randomized phase 3 study;Boku;Lancet Oncol,2009

5. Irinotecan (CPT-11) and cisplatin as first-line chemotherapy for advanced ovarian cancer;Sugiyama;Oncology,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Correlation Between UGT1A1 Gene Phenotypes and the Clinical Prognosis of Advanced Colorectal Cancer After FOLFIRI Therapy;Cancer Biotherapy and Radiopharmaceuticals;2021-11-01

2. Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors;Archives of Toxicology;2020-05-15

3. Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome;Medicine;2020-02

4. Therapeutic implications of germline genetic findings in cancer;Nature Reviews Clinical Oncology;2019-02-19

5. A phase II trial of irinotecan in patients with advanced or recurrent endometrial cancer and correlation with biomarker analysis;Gynecologic Oncology;2018-09